Dosing Woes For VBI Vaccines As Share Price Plummets On Hep B Study Results

Arch_Hands
The PROTECT study tested Sci-B-Vac against GSK's Engerix-B • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category